Advances in genomic, proteomic, metabolomic techniques led to the discovery of tumor biomarkers including cell surface receptors (tyrosine kinase receptors, cell adhesion receptors, cell death receptors) [8,9,10]. The gene discussed is NTRK1; the disease is neoplasm.